Financials
- Market Capitalization 153.7 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.03
Fiyat/satışlar oranı
47.35
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3736 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | -3.03% | -28.09% | +55.15% | 155.81 M USD | ||
| 3739 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | -1.43% | -8.00% | -40.00% | 154.72 M USD | ||
| 3744 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.15 USD | -0.86% | -10.16% | -34.66% | -39.47% | 153.23 M USD | ||
| 3749 | LENZ LENZ Therapeutics, Inc. - Common Stock | 4.84 USD | +0.62% | +2.54% | -16.70% | -85.11% | 152.07 M USD |